IDEX Biometrics ASA
IDBA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,126 | $1,662 | $5,322 | $4,326 |
| - Cash | $11 | $16 | $34 | $7 |
| + Debt | $7 | $12 | $0 | $1 |
| Enterprise Value | $1,122 | $1,657 | $5,289 | $4,320 |
| Revenue | $4 | $4 | $3 | $1 |
| % Growth | 1.5% | 44.1% | 159.4% | – |
| Gross Profit | $0 | $1 | $2 | $1 |
| % Margin | 5.6% | 20.7% | 55.8% | 74.9% |
| EBITDA | -$274 | -$30 | -$30 | -$25 |
| % Margin | -6,595.7% | -731.2% | -1,040% | -2,251.8% |
| Net Income | -$27 | -$33 | -$33 | -$27 |
| % Margin | -643.4% | -798.1% | -1,146.1% | -2,442.9% |
| EPS Diluted | -1.07 | -0.15 | -0.2 | -0.15 |
| % Growth | -613.3% | 25% | -33.3% | – |
| Operating Cash Flow | -$27 | -$32 | -$27 | -$23 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$27 | -$32 | -$28 | -$24 |